Born in Avilés, Asturias, in 1974. Biochemist by University of Salamanca (1997) and PhD in Medicine (Hematology) by the same University in 2002, under the supervision of Prof. Alberto Orfao and Prof. Jesus San Miguel. Postdoctoral training in stem cell biology (Mick Bhatia Laboratory, London, ON, Canada; 2002-2005) and in childhood leukemia (Mel Greaves Laboratory, London, UK; 2005-2007). In 2007, I was appointed Director of the Andalusian Stem Cell Bank, and was leading my own lab at CIBM (Granada, Spain) until July 2011 when I moved to GENyO (Granada, Spain) as Principal Invesigator. In June 2013 I was appointed ICREA Research Professor and coordinator of Clinic campus of The Josep Carreras Leukemia Research Institute (Barcelona).
Research interests
1.-Understanding the etiology, pathogenesis and cellular origin of MLL-rearranged and MLL-germline pediatric Acute Lymphoblastic Leukemia.
2.-Leukemic cell-bone marrow environment interactions and targeted therapies in Acute Myeloid Leukemia and therapy resistance.
3.- Adoptive T-cell-based CAR immunotherapy for B-cell, T-cell ALL, AML and bone sarcomas.
4.-Deciphering the intrinsic determinants and signaling pathways underlying hematopoietic from human pluripotent stem cells.
Selected publications
- Díez-Alonso L et al.2024, 'Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo. Sci Transl Med, 16-7962
- Molina, O et al. 2024, 'Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression', Embo molecular medicine, 16 - 1 - 64 - 92.
- Bousquets-Muñoz P et al. Backtracking NOM1::ETV6 fusion to neonatal pathogenesis of t(7;12) (q36;p13) infant AML, Leukemia, 38-1808-1812.
- Mensurado S et al. CD155/PVR determines acute myeloid leukemia Delta One T cells. Blood 2024;143:1488-1495.
- Velasco T, Trincado JL, Menendez P et al 2024 'A comprehensive single-cell expression atlas of human AML leukemia-initiating cells unravels the contribution of HIF pathway and its therapeutic potential', Hemasphere, 26 - 8 - 2 - e45.
- Guerrero M et al 2024,'Integrative single-cell multi-omics of CD19-CARpos and CARneg T cells suggest drivers of immunotherapy response in B cell neoplasias', Cell Rep Med, 5-101803.
- Panisello C et al. NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid-lymphoid representation with limited graft-versus-host-disease, J ImmunoTher Cancer 2024;12:e009198.
- Sjövall D, et al. Defective ribosome assembly impairs leukemia progression in a murine model of acute myeloid leukemia. Cell reports, 2024; 43: 114864.
- Lopez-Millan, B et al. 2024, 'NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expression', Blood, 144 - 19 - 2002 - 2017.
- Petazzi P et al. 2024, 'A novel human pluripotent stem cell-based gene activation system identifies IGFBP2 as a mediator in the production of hematopoietic progenitors in vitro', eLife, 13- RP94884.
Selected research activities
Board of Directors ISEH 2024-2026
PhD dissertations
8 inveted international conferences